Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Environ Health Perspect ; 123(12): 1232-40, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25956009

RESUMO

BACKGROUND: Safety assessment for repeated dose toxicity is one of the largest challenges in the process to replace animal testing. This is also one of the proof of concept ambitions of SEURAT-1, the largest ever European Union research initiative on alternative testing, co-funded by the European Commission and Cosmetics Europe. This review is based on the discussion and outcome of a workshop organized on initiative of the SEURAT-1 consortium joined by a group of international experts with complementary knowledge to further develop traditional read-across and include new approach data. OBJECTIVES: The aim of the suggested strategy for chemical read-across is to show how a traditional read-across based on structural similarities between source and target substance can be strengthened with additional evidence from new approach data--for example, information from in vitro molecular screening, "-omics" assays and computational models--to reach regulatory acceptance. METHODS: We identified four read-across scenarios that cover typical human health assessment situations. For each such decision context, we suggested several chemical groups as examples to prove when read-across between group members is possible, considering both chemical and biological similarities. CONCLUSIONS: We agreed to carry out the complete read-across exercise for at least one chemical category per read-across scenario in the context of SEURAT-1, and the results of this exercise will be completed and presented by the end of the research initiative in December 2015.


Assuntos
Alternativas aos Testes com Animais , Testes de Toxicidade/métodos , Segurança Química , Simulação por Computador , Tomada de Decisões , União Europeia , Humanos , Relação Quantitativa Estrutura-Atividade , Testes de Toxicidade/normas
2.
Regul Toxicol Pharmacol ; 62(2): 393-403, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22085589

RESUMO

Validated in vitro methods for skin corrosion and irritation were adopted by the OECD and by the European Union during the last decade. In the EU, Switzerland and countries adopting the EU legislation, these assays may allow the full replacement of animal testing for identifying and classifying compounds as skin corrosives, skin irritants, and non irritants. In order to develop harmonised recommendations on the use of in vitro data for regulatory assessment purposes within the European framework, a workshop was organized by the Swiss Federal Office of Public Health together with ECVAM and the BfR. It comprised stakeholders from various European countries involved in the process from in vitro testing to the regulatory assessment of in vitro data. Discussions addressed the following questions: (1) the information requirements considered useful for regulatory assessment; (2) the applicability of in vitro skin corrosion data to assign the corrosive subcategories as implemented by the EU Classification, Labelling and Packaging Regulation; (3) the applicability of testing strategies for determining skin corrosion and irritation hazards; and (4) the applicability of the adopted in vitro assays to test mixtures, preparations and dilutions. Overall, a number of agreements and recommendations were achieved in order to clarify and facilitate the assessment and use of in vitro data from regulatory accepted methods, and ultimately help regulators and scientists facing with the new in vitro approaches to evaluate skin irritation and corrosion hazards and risks without animal data.


Assuntos
Cáusticos/toxicidade , Irritantes/toxicidade , Medição de Risco/legislação & jurisprudência , Pele/efeitos dos fármacos , Alternativas aos Testes com Animais , Animais , União Europeia , Feminino , Masculino , Suíça
3.
Environ Health Perspect ; 117(1): 17-25, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19165382

RESUMO

OBJECTIVE: We conducted a review of the history and performance of developmental neurotoxicity (DNT) testing in support of the finalization and implementation of Organisation of Economic Co-operation and Development (OECD) DNT test guideline 426 (TG 426). INFORMATION SOURCES AND ANALYSIS: In this review we summarize extensive scientific efforts that form the foundation for this testing paradigm, including basic neurotoxicology research, interlaboratory collaborative studies, expert workshops, and validation studies, and we address the relevance, applicability, and use of the DNT study in risk assessment. CONCLUSIONS: The OECD DNT guideline represents the best available science for assessing the potential for DNT in human health risk assessment, and data generated with this protocol are relevant and reliable for the assessment of these end points. The test methods used have been subjected to an extensive history of international validation, peer review, and evaluation, which is contained in the public record. The reproducibility, reliability, and sensitivity of these methods have been demonstrated, using a wide variety of test substances, in accordance with OECD guidance on the validation and international acceptance of new or updated test methods for hazard characterization. Multiple independent, expert scientific peer reviews affirm these conclusions.


Assuntos
Guias como Assunto , Sistema Nervoso/efeitos dos fármacos , Testes de Toxicidade , Humanos , Sistema Nervoso/crescimento & desenvolvimento , Estudos Retrospectivos , Medição de Risco
4.
Crit Rev Toxicol ; 37(1-2): 1-4, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17364702

RESUMO

This issue presents the detailed review paper (DRP) on thyroid hormone disruption assays that was prepared for the Organization for Economic Cooperation and Development (OECD) and that exists as an OECD monograph. However, this document is now available here in one issue of Critical Reviews in Toxicology as a series of published articles. The original document has been modified in several ways. First, an overview (now article 2) was added to discuss how new data and new directions for thyroid research will play an important role in shaping thyroid assays as they evolve. Second, each of the original chapters of the thyroid DRP have been separated into individual papers. The appendices of the original DRP were removed and will be merged and published separately.


Assuntos
Bioensaio/métodos , Hormônios Tireóideos/metabolismo , Animais , Bioensaio/história , Bioensaio/tendências , História do Século XX , Humanos , Publicações Periódicas como Assunto/tendências , Literatura de Revisão como Assunto , Doenças da Glândula Tireoide/metabolismo , Doenças da Glândula Tireoide/prevenção & controle , Hormônios Tireóideos/fisiologia , Toxicologia/métodos , Toxicologia/organização & administração , Toxicologia/tendências
7.
Chem Biol Interact ; 142(3): 269-83, 2003 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-12453665

RESUMO

Possible xenobiotic interactions with thiamine were studied in salmonid fish, by repeatedly injecting two model substances, paraquat and menadione, into juvenile rainbow trout (Oncorhynchus mykiss). These two substances were chosen because of their well-known ability to redox-cycle and cause depletion of NADPH in several biological systems. Depletion of NADPH increases metabolism through the pentose-phosphate shunt and may thereby increase the need for thiamine diphosphate by heightened transketolase activity. A special food was produced with lower thiamine content than commercial food, usually enriched with thiamine, which could mask an effect on the thiamine level. After 9 weeks of exposure, glucose-6-phosphate dehydrogenase, transketolase, glutathione reductase and ethoxyresorufin O-deethylase were analysed in liver and kidney cellular sub-fractions as well as analysis of total thiamine concentrations in liver, kidney and muscle. The results showed that paraquat caused a large increase in hepatic glutathione reductase activity and induced hepatic glucose-6-phosphate dehydrogenase activity, i.e., the rate-limiting enzyme in the oxidative part of the pentose-phosphate shunt. Despite this paraquat exposure did not affect transketolase activity and total thiamine concentration.


Assuntos
Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Paraquat/toxicidade , Via de Pentose Fosfato/efeitos dos fármacos , Tiamina/metabolismo , Vitamina K 3/farmacologia , Animais , Feminino , Glucosefosfato Desidrogenase/metabolismo , Glutationa Redutase/metabolismo , Masculino , NADP/metabolismo , Oncorhynchus mykiss , Oxirredução , Transcetolase/metabolismo , Xenobióticos/toxicidade
8.
Aquat Toxicol ; 61(1-2): 15-33, 2002 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-12297368

RESUMO

Sea-run Baltic salmon (Salmo salar) populations are suffering from the M74 syndrome, a reproduction disorder affecting both broodfish and their progeny. The syndrome is usually manifested during the middle part of the yolk-sac fry stage and has been shown to be associated with a thiamine (vitamin B(1)) deficiency. Development of the disease is reversible by thiamine treatments of broodfish or progeny. This study aimed at investigating the ability of the thiamine antagonist pyrithiamine, administered by microinjections 3 days after hatch, to cause M74-like signs i.e. typical clinical symptoms, high mortality rates and histopathological changes. Furthermore, the effects of pyrithiamine on hepatic activities of the thiamine-dependent enzyme transketolase (TK), the glucose-6-phosphate dehydrogenase (G6PDH) and the cytochrome P4501A (CYP1A) were evaluated. Six family groups with differing thiamine status were sampled on three occasions during the yolk-sac fry stage. All pyrithiamine exposed groups, with the exception of the one with the highest thiamine concentration, showed M74-like symptoms and suffered from high mortality. Enzyme activities were not different in pyrithiamine groups as compared with controls. However, the TK-activities were strongly associated with the thiamine concentrations. The G6PDH-activity demonstrated small variations with the highest activities in the M74-groups. The [TK]/[G6PDH]-ratios were considerably lower in the M74-groups than in the healthy controls, indicating an imbalance between the oxidative and the non-oxidative part of the pentose-phosphate shunt due to a deficit in thiamine. The pyrithiamine-injections induced several M74-like symptoms including incoordination, lethargy, whitened liver and yolk-sac precipitates. They also caused high mortality rates, in addition to lowered glycogen levels and increased prevalence of necrotic brain cells. Moreover, the study demonstrates that the TK, G6PDH and CYP1A-activities are associated with the thiamine content.


Assuntos
Salmo salar/fisiologia , Deficiência de Tiamina/veterinária , Animais , Antimetabólitos/farmacologia , Citocromo P-450 CYP1A1/farmacologia , Embrião não Mamífero/efeitos dos fármacos , Fígado/patologia , Mortalidade , Piritiamina/farmacologia , Síndrome , Deficiência de Tiamina/etiologia , Saco Vitelino/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...